Edwards Lifesciences Corp (EW)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	5,997,700	5,823,000	5,652,900	5,488,400	5,362,000	5,360,300	5,343,800	5,344,000	5,219,100	5,093,000	4,925,300	4,477,100	4,393,400	4,375,800	4,330,900	4,493,400	4,355,200	4,158,800	3,968,100	3,822,500
Total assets	US$ in thousands	9,363,200	9,370,800	9,004,000	8,651,200	8,292,500	8,638,200	8,425,100	8,419,900	8,502,600	8,160,300	7,662,100	7,213,700	7,237,100	6,800,800	6,424,100	6,076,100	6,488,100	5,966,300	5,573,500	5,469,300
Total asset turnover		0.64	0.62	0.63	0.63	0.65	0.62	0.63	0.63	0.61	0.62	0.64	0.62	0.61	0.64	0.67	0.74	0.67	0.70	0.71	0.70

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $5,997,700K ÷ $9,363,200K
= 0.64

The total asset turnover ratio for Edwards Lifesciences Corp has been relatively stable over the past eight quarters, ranging from 0.62 to 0.65. This indicates that, on average, the company generates approximately $0.62 to $0.65 in revenue for every dollar of total assets it holds. A total asset turnover ratio below 1 suggests that the company is not generating enough sales relative to its asset base, which could indicate inefficiency in asset utilization. However, the consistency of the ratio within a narrow range suggests that Edwards Lifesciences Corp has been maintaining a steady level of efficiency in generating revenue with its assets. Further analysis and benchmarking against industry peers could provide more insights into the company's asset utilization performance.